RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+9.58%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$5.45B
AUM Growth
+$5.45B
(+0.56%)
Cap. Flow
+$83.4M
Cap. Flow
% of AUM
1.53%
Top 10 Holdings %
Top 10 Hldgs %
47.61%
Holding
95
New
15
Increased
22
Reduced
33
Closed
14
Top Buys
| 1 |
Gilead Sciences
GILD
|
$181M |
| 2 |
OSH
Oak Street Health, Inc.
OSH
|
$142M |
| 3 |
Annexon
ANNX
|
$104M |
| 4 |
Nurix Therapeutics
NRIX
|
$90.5M |
| 5 |
Kymera Therapeutics
KYMR
|
$88.3M |
Top Sells
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$162M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$157M |
| 3 |
BioNTech
BNTX
|
$127M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$64.2M |
| 5 |
CryoPort
CYRX
|
$55M |
Sector Composition
| 1 | Healthcare | 92.54% |
| 2 | Financials | 0.5% |
| 3 | Technology | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SelectQuote
SLQT
$391M
| $27.4M | 0.5% | 1,355,304 +858,432 | +173% | +$17.4M |
|
|
TCDA
52
DELISTED
Tricida, Inc. Common Stock
TCDA
| $25.9M | 0.48% | 2,858,415 +739,415 | +35% | +$6.7M |
|
|
LMNX
53
DELISTED
Luminex Corp
LMNX
| $24M | 0.44% | 914,107 -3,800 | -0.4% | -$99.7K |
|
|
EIDX
54
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $23.6M | 0.43% | 466,205 -127,637 | -21% | -$6.45M |
|
55
Immatics
IMTX
$619M
| $22.6M | 0.41% | +2,130,000 | New | +$22.6M |
|
56
Ardelyx
ARDX
$1.53B
| $18.4M | 0.34% | 3,514,100 | – | – |
|
|
HOOK
57
DELISTED
HOOKIPA Pharma
HOOK
| $17.5M | 0.32% | 1,842,902 -17,708 | -1% | -$168K |
|
58
Cytosorbents Corp
CTSO
$59.2M
| $16.8M | 0.31% | +2,101,131 | New | +$16.8M |
|
59
ALX Oncology
ALXO
$62.7M
| $15.4M | 0.28% | +407,400 | New | +$15.4M |
|
60
Cabaletta Bio
CABA
$133M
| $15M | 0.28% | 1,386,584 -39,312 | -3% | -$426K |
|
|
PROF
61
Profound Medical
PROF
$134M
| $14.6M | 0.27% | 825,000 +425,000 | +106% | +$7.5M |
|
62
Xeris Biopharma Holdings
XERS
$1.26B
| $14.2M | 0.26% | 2,397,441 | – | – |
|
|
PAND
63
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $12.8M | 0.24% | +1,119,600 | New | +$12.8M |
|
|
ITMR
64
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $12.7M | 0.23% | 625,000 | – | – |
|
|
CBAY
65
DELISTED
Cymabay Therapeutics
CBAY
| $12.4M | 0.23% | 1,719,247 +44,800 | +3% | +$324K |
|
|
FSDC
66
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $11.2M | 0.21% | +1,000,000 | New | +$11.2M |
|
67
GoodRx Holdings
GDRX
$1.51B
| $11.1M | 0.2% | +200,000 | New | +$11.1M |
|
68
Stereotaxis
STXS
$261M
| $11.1M | 0.2% | 3,103,327 | – | – |
|
69
Dynavax Technologies
DVAX
$1.19B
| $11M | 0.2% | 2,548,620 -2,513,480 | -50% | -$10.9M |
|
|
NVTA
70
DELISTED
Invitae Corporation
NVTA
| $8.45M | 0.16% | 195,003 -236,097 | -55% | -$10.2M |
|
|
GRTS
71
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $8.11M | 0.15% | 3,059,794 -5,200 | -0.2% | -$13.8K |
|
|
AYLA
72
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
| $7.85M | 0.14% | 666,666 | – | – |
|
73
Immunovant
IMVT
$2.56B
| $4.26M | 0.08% | 120,940 -479,060 | -80% | -$16.9M |
|
74
Outset Medical
OM
$247M
| $3.5M | 0.06% | +70,000 | New | +$3.5M |
|
|
SYRS
75
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.88M | 0.03% | 212,291 | – | – |
|